Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 2298 [2012-650]

Download as PDF 2298 Federal Register / Vol. 77, No. 10 / Tuesday, January 17, 2012 / Notices the two groups. The video simulation will be approximately four-hour long total. All students will take a pre-test quiz when they fill out the demographics form. Once the treatment is completed, all students will be asked to take a post-test quiz and answer a post-viewing questionnaire to capture part of the study, in person or on the phone, before and after he/she uses the video simulation. Participants for the focus groups will be selected from the students who participate in the first part of the study. The focus group will last one hour. their perceptions of the video simulation. To answer the second question, the study will collect qualitative data from semi-structured interviews as well as focus groups. The semi-structured interviews will be conducted twice with faculty who teach the courses in the first ESTIMATED ANNUALIZED BURDEN TABLE Forms Type of respondent Number of respondents Number of responses per respondent Average burden (in hours) per response Total burden hours Educational Interactive Video ........... Individuals/Households .................... 3000 1 14/60 700 Keith A. Tucker, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2012–632 Filed 1–13–12; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Office of the Assistant Secretary for Health, Presidential Commission for the Study of Bioethical Issues, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: The Presidential Commission for the Study of Bioethical Issues will conduct its eighth meeting in February. At this meeting, the Commission will discuss issues of privacy and access related to human genome sequence data. The Commission will also be discussing neuroscience and related ethical issues. DATES: The meeting will take place February 2, 2012 from 9 a.m. to approximately 5:15 p.m. and on February 3, 2012 from 9 a.m. to approximately 12 p.m. ADDRESSES: Millberry Union, University of California, San Francisco, 500 Parnassus Avenue, San Francisco, CA 94143, (415) 476–2019. FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C–100, Washington, DC 20005. Telephone: (202) 233–3960. Email: Hillary.Viers@ bioethics.gov. Additional information may be obtained at https:// www.bioethics.gov. srobinson on DSK4SPTVN1PROD with NOTICES SUMMARY: Pursuant to the Federal Advisory Committee Act SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 16:12 Jan 13, 2012 Jkt 226001 of 1972, Public Law 92–463, 5 U.S.C. app. 2, notice is hereby given of the eighth meeting of the Presidential Commission for the Study of Bioethical Issues (the Commission). The meeting will be held from 9 a.m. to approximately 5:15 p.m. on Thursday, February 2, 2012, and from 9 a.m. to approximately 12 p.m. on Friday, February 3, 2012, in San Francisco, California. The meeting will be open to the public with attendance limited to space available. The meeting will also be webcast at https://www.bioethics.gov. Under authority of Executive Order 13521, dated November 24, 2009, the President established the Commission. The Commission is an advisory panel of the nation’s leaders in medicine, science, ethics, religion, law, and engineering. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The main agenda item for the Commission’s eighth meeting is to discuss issues of privacy and access related to human genome sequence data. The Commission will also be discussing neuroscience and related ethical issues. The draft meeting agenda and other information about PCSBI, including information about access to the webcast, will be available at https://www.bioethics.gov. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Respectful debate of opposing views and active participation by citizens in public exchange of ideas can enhance decisions that are reached and the overall public understanding of them. The Commission is particularly interested in receiving comments and PO 00000 Frm 00042 Fmt 4703 Sfmt 9990 questions during the meeting that are responsive to specific sessions. Written comments will be accepted at the registration desk and comment forms will be provided for members of the public to write down questions and comments for the Commission as they arise. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the Commission may make a random selection. Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 233–3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Written comments will also be accepted in advance of the meeting and are especially welcome. Please address written comments by email to info@bioethics.gov, or by mail to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Ave. NW., Suite C–100, Washington, DC 20005. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Dated: January 6, 2012. Valerie H. Bonham, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2012–650 Filed 1–13–12; 8:45 am] BILLING CODE 4154–06–P E:\FR\FM\17JAN1.SGM 17JAN1

Agencies

[Federal Register Volume 77, Number 10 (Tuesday, January 17, 2012)]
[Notices]
[Page 2298]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-650]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Office of the Assistant Secretary for Health, Presidential 
Commission for the Study of Bioethical Issues, Department of Health and 
Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
will conduct its eighth meeting in February. At this meeting, the 
Commission will discuss issues of privacy and access related to human 
genome sequence data. The Commission will also be discussing 
neuroscience and related ethical issues.

DATES: The meeting will take place February 2, 2012 from 9 a.m. to 
approximately 5:15 p.m. and on February 3, 2012 from 9 a.m. to 
approximately 12 p.m.

ADDRESSES: Millberry Union, University of California, San Francisco, 
500 Parnassus Avenue, San Francisco, CA 94143, (415) 476-2019.

FOR FURTHER INFORMATION CONTACT: Hillary Wicai Viers, Communications 
Director, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 
(202) 233-3960. Email: Hillary.Viers@bioethics.gov. Additional 
information may be obtained at https://www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the eighth meeting of the Presidential Commission for the Study of 
Bioethical Issues (the Commission). The meeting will be held from 9 
a.m. to approximately 5:15 p.m. on Thursday, February 2, 2012, and from 
9 a.m. to approximately 12 p.m. on Friday, February 3, 2012, in San 
Francisco, California. The meeting will be open to the public with 
attendance limited to space available. The meeting will also be webcast 
at https://www.bioethics.gov. Under authority of Executive Order 13521, 
dated November 24, 2009, the President established the Commission. The 
Commission is an advisory panel of the nation's leaders in medicine, 
science, ethics, religion, law, and engineering. The Commission advises 
the President on bioethical issues arising from advances in biomedicine 
and related areas of science and technology. The Commission seeks to 
identify and promote policies and practices that ensure scientific 
research, health care delivery, and technological innovation are 
conducted in a socially and ethically responsible manner. The main 
agenda item for the Commission's eighth meeting is to discuss issues of 
privacy and access related to human genome sequence data. The 
Commission will also be discussing neuroscience and related ethical 
issues. The draft meeting agenda and other information about PCSBI, 
including information about access to the webcast, will be available at 
https://www.bioethics.gov. The Commission welcomes input from anyone 
wishing to provide public comment on any issue before it. Respectful 
debate of opposing views and active participation by citizens in public 
exchange of ideas can enhance decisions that are reached and the 
overall public understanding of them. The Commission is particularly 
interested in receiving comments and questions during the meeting that 
are responsive to specific sessions. Written comments will be accepted 
at the registration desk and comment forms will be provided for members 
of the public to write down questions and comments for the Commission 
as they arise. To accommodate as many individuals as possible, the time 
for each question or comment may be limited. If the number of 
individuals wishing to pose a question or make a comment is greater 
than can reasonably be accommodated during the scheduled meeting, the 
Commission may make a random selection. Anyone planning to attend the 
meeting who needs special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify Esther 
Yoo by telephone at (202) 233-3960, or email at 
Esther.Yoo@bioethics.gov in advance of the meeting. The Commission will 
make every effort to accommodate persons who need special assistance. 
Written comments will also be accepted in advance of the meeting and 
are especially welcome. Please address written comments by email to 
info@bioethics.gov, or by mail to the following address: Public 
Commentary, Presidential Commission for the Study of Bioethical Issues, 
1425 New York Ave. NW., Suite C-100, Washington, DC 20005. Comments 
will be publicly available, including any personally identifiable or 
confidential business information that they contain. Trade secrets 
should not be submitted.

    Dated: January 6, 2012.
Valerie H. Bonham,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2012-650 Filed 1-13-12; 8:45 am]
BILLING CODE 4154-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.